Healthcare news

Featured image of the article Emerging Therapeutic mRNA Innovators Revealed by Patent Monitoring: A PopVax IP Analysis.

Emerging Therapeutic mRNA Innovators Revealed by Patent Monitoring: A PopVax IP Analysis

Posted on by

SOPHIA ANTIPOLIS, France – January 16, 2026 │ This quarter, KnowMade’s Therapeutic mRNA patent monitoring service highlights PopVax as an emerging innovator driving multivalent mRNA vaccines and next-generation delivery platforms. Identifying Emerging mRNA Innovators Through Patent Surveillance: The Case of PopVax Patent Monitoring as a Strategic Lens on Therapeutic mRNA Innovation Patent monitoring has become[…]

Featured image of the article Building the Future of Oncology: Takeda and Innovent Partner on Breakthrough ADC Therapies.

Building the Future of Oncology: Takeda and Innovent Partner on Breakthrough ADC Therapies

Posted on by

SOPHIA ANTIPOLIS, France – November 21, 2025 │ October 21, 2025 – Takeda has entered into a license and collaboration agreement with Innovent Biologics for the development, manufacturing and commercialization of two late-stage oncology medicines, worldwide outside of Greater China. First, there is IBI363, a PD-1/IL-2α-bias bispecific antibody fusion protein, evaluated in non-small cell lung[…]

Featured image of the article Hansoh Pharma and Roche forge global alliance to advance CDH17-targeting ADCs for solid tumors.

Hansoh Pharma and Roche forge global alliance to advance CDH17-targeting ADCs for solid tumors

Posted on by

SOPHIA ANTIPOLIS, France – October 24, 2025 │ Hansoh Pharmaceutical has signed a license agreement with Roche to develop HS-20110, a CDH17-targeting antibody-drug conjugate (ADC) utilizing a clinically validated topoisomerase inhibitor payload. Hansoh Pharma gives Roche an exclusive worldwide license (excluding the Chinese Mainland, Hong Kong, Macau and Taiwan) to advance the clinical development and[…]

Featured image of the article Next-Generation mRNA Innovators: Pioneering RNA Delivery and Methane-Targeting Vaccines

Next-Generation mRNA Innovators: Pioneering RNA Delivery and Methane-Targeting Vaccines

Posted on by

SOPHIA ANTIPOLIS, France – October 17, 2025 │ This quarter, KnowMade’s Therapeutic mRNA patent monitoring service reveals two emerging players shaping the next wave of RNA innovation: Parcel Bio, pioneering nanoparticle-free delivery, and ArkeaBio, developing mRNA vaccines for methane mitigation. Two Emerging Players Expand the Frontiers of Therapeutic mRNA Innovation Two new entrants have emerged[…]